Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Mouse SIRP alpha ELISA Kit (AC3879)
Cat.#: ASET-2468
Specifications
Description Mouse SIRP alpha ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse SIRP alpha concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.84 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 150-2400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1950 Rat GRINA ELISA Kit (AC3361) Quantitative inquiry ASET-1910 Human C Peptide ELISA Kit (AC3321) Quantitative inquiry ASET-1924 Mouse NF-kB p65 ELISA Kit (AC3335) Quantitative inquiry ASET-2075 Human PROKR2 ELISA Kit (AC3486) Quantitative inquiry ASET-1247 Human GSK3 beta ELISA Kit (AC2658) Quantitative inquiry ASET-1633 Monkey GAP43 ELISA Kit (AC3044) Quantitative inquiry ASET-1473 Human NTE ELISA Kit (AC2884) Quantitative inquiry ASET-1527 Mouse Neuropeptide Y ELISA Kit (AC2938) Quantitative inquiry ASET-2191 Rat SNAP25 ELISA Kit (AC3602) Quantitative inquiry ASET-2021 Human Progesterone Receptor ELISA Kit (AC3432) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket